EUVIMEDOpdag EUVIMED
Open access

Exploring the role of phase separation in TDP ‐43 pathogenesis with ArtiTDP43

Eric Chevet iD

The FEBS Journal · 2026-07 · 293 (14) · 4145-4148

DOI: 10.1111/febs.70577 ↗

At a glance

Journal article in The FEBS Journal, published online on 2026-05-02. Written by Eric Chevet. Institution: Inserm U1242, University of Rennes, Rennes, France. Major MEDLINE topics: DNA-Binding Proteins, Amyotrophic Lateral Sclerosis. 8 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

TDP‐43 is a nuclear RNA‐binding protein implicated in neurodegenerative diseases such as ALS and FTLD, where it becomes mislocalized to the cytoplasm and forms pathological aggregates. These aggregates are thought to arise through liquid–liquid phase separation, a process by which proteins form dynamic, membrane‐less condensates that can mature into solid structures. To better understand this process, the authors developed ArtiTDP43, a chemically controllable system that enables reversible formation of TDP‐43 condensates in cells. Using this tool, they showed that TDP‐43 forms different structures depending on its concentration: small liquid‐like puncta, intermediate condensates associated with stress granules, and large solid aggregates resembling disease pathology. These transitions are reversible at early stages but become irreversible as aggregates solidify. The study by Combe et al. demonstrates that increasing cytoplasmic TDP‐43 concentration drives a liquid‐to‐solid transition, while oxidative stress accelerates this process and promotes pathological features such as phosphorylation and p62 recruitment. Importantly, formation of cytoplasmic aggregates leads to depletion of nuclear TDP‐43 and increased cell death, indicating toxicity. Overall, the findings establish a mechanistic link between phase separation, aggregation, and cytotoxicity in TDP‐43 proteinopathies. ArtiTDP43 provides a powerful tool to study early disease mechanisms and explore therapeutic strategies aimed at preventing pathological aggregation or maintaining normal TDP‐43 dynamics.

Subjects

MeSH terms (MEDLINE)

DNA-Binding ProteinsAmyotrophic Lateral SclerosisPhase SeparationHumansOxidative StressStress GranulesCytoplasmPhosphorylationProtein Aggregates

Author keywords

ALSArtiTDP‐43FTLDLLPSTDP‐43aggregationcondensatescytotoxicityoxidative stressphase separation

Substances

DNA-Binding ProteinsTARDBP protein, humanProtein Aggregates

Authors and institutions

  • Inserm U1242, University of Rennes, Rennes, France.
  • Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France.

ORCID profiles: Eric Chevet

Cite

APA

Chevet, E. (2026). Exploring the role of phase separation in TDP ‐43 pathogenesis with ArtiTDP43. The FEBS Journal, 293(14), 4145-4148. https://doi.org/10.1111/febs.70577

Vancouver

Chevet E. Exploring the role of phase separation in TDP ‐43 pathogenesis with ArtiTDP43. The FEBS Journal. 2026;293(14):4145-4148. doi:10.1111/febs.70577

BibTeX
@article{Chevet2026,
  author = {Chevet, Eric},
  title = {Exploring the role of phase separation in TDP ‐43 pathogenesis with ArtiTDP43},
  journal = {The FEBS Journal},
  year = {2026},
  volume = {293},
  number = {14},
  pages = {4145--4148},
  doi = {10.1111/febs.70577}
}
Start for free →